Sarcopenia: Preventable and Reversible

  • Alfonso J. Cruz-JentoftEmail author
Part of the Practical Issues in Geriatrics book series (PIG)


Sarcopenia is a progressive and generalized loss of skeletal muscle mass and function that increases the risk of adverse outcomes (death, functional decline, reduced quality of life) in old age. Sarcopenia develops along the lifetime, starting early in life and accelerating after age 50. This condition is preventable by incorporating resistance exercise and improving nutrition (especially protein intake) to a healthy lifestyle, and prevention or retardation of sarcopenia may have an impact on the incidence of disability. When sarcopenia is present, it is also potentially reversible by a comprehensive exercise program associated with a dietary intervention.


Sarcopenia Resistance exercise Healthy diet Protein intake 


  1. 1.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 39(4):412–423CrossRefGoogle Scholar
  2. 2.
    Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S–991SCrossRefGoogle Scholar
  3. 3.
    Morley JE, Cruz-Jentoft AJ (2012) Definitions of sarcopenia. In: Cruz-Jentoft AJ, Morley JE (eds) Sarcopenia. Wiley-Blackwell, Hoboken, NJ, pp 8–19CrossRefGoogle Scholar
  4. 4.
    Cruz-Jentoft AJ (2016) Sarcopenia, the last organ insufficiency. Eur Geriatr Med 7(3):195–196CrossRefGoogle Scholar
  5. 5.
    Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6):748–759CrossRefGoogle Scholar
  6. 6.
    Beaudart C, Zaaria M, Pasleau F, Reginster J-Y, Bruyère O (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 12(1):e0169548CrossRefGoogle Scholar
  7. 7.
    Beaudart C, Reginster J-Y, Geerinck A, Locquet M, Bruyère O (2017) Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia. Expert Rev Pharmacoecon Outcomes Res 17(4):335–341CrossRefGoogle Scholar
  8. 8.
    Ethgen O, Beaudart C, Buckinx F, Bruyère O, Reginster JY (2017) The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int 100(3):229–234CrossRefGoogle Scholar
  9. 9.
    Antunes AC, Araújo DA, Veríssimo MT, Amaral TF (2017) Sarcopenia and hospitalisation costs in older adults: a cross-sectional study. Nutr Diet J Dietit Assoc Aust 74(1):46–50Google Scholar
  10. 10.
    Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C (2008) The developmental origins of sarcopenia. J Nutr Health Aging 12(7):427–432CrossRefGoogle Scholar
  11. 11.
    Shaw SC, Dennison EM, Cooper C (2017) Epidemiology of sarcopenia: determinants throughout the Lifecourse. Calcif Tissue Int 101(3):229–247CrossRefGoogle Scholar
  12. 12.
    Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N et al (2017) Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int 28(6):1817–1833CrossRefGoogle Scholar
  13. 13.
    Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I et al (2017) Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr 37(4):1121–1132. [Epub ahead of print]CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Naseeb MA, Volpe SL (2017) Protein and exercise in the prevention of sarcopenia and aging. Nutr Res 40:1–20CrossRefGoogle Scholar
  15. 15.
    Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE et al (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 14(8):542–559CrossRefGoogle Scholar
  16. 16.
    Deutz NEP, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A et al (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 33(6):929–936CrossRefGoogle Scholar
  17. 17.
    Denison HJ, Cooper C, Sayer AA, Robinson SM (2015) Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging 10:859–869PubMedPubMedCentralGoogle Scholar
  18. 18.
    Rondanelli M, Miccono A, Peroni G, Guerriero F, Morazzoni P, Riva A et al (2016) A systematic review on the effects of botanicals on skeletal muscle health in order to prevent sarcopenia. Evid Based Complement Alternat Med 2016:5970367CrossRefGoogle Scholar
  19. 19.
    Morley JE (2016) Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 98(4):319–333CrossRefGoogle Scholar
  20. 20.
    Rooks D, Praestgaard J, Hariry S, Laurent D, Petricoul O, Perry RG et al (2017) Treatment of sarcopenia with Bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study. J Am Geriatr Soc 65(9):1988–1995CrossRefGoogle Scholar
  21. 21.
    Law TD, Clark LA, Clark BC (2016) Resistance exercise to prevent and manage sarcopenia and dynapenia. Annu Rev Gerontol Geriatr 36(1):205–228CrossRefGoogle Scholar
  22. 22.
    Malafarina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L (2013) Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc 14(1):10–17CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Hospital Universitario Ramón y Cajal (IRYCS)MadridSpain

Personalised recommendations